-
Something wrong with this record ?
N-(2-Hydroxyethyl)-L-valyl-L-leucine in rat urine as a hydrolytic cleavage product of ethylene oxide adduct with globin
J. Mráz, I. Hanzlíková, I. Linhart, Š. Dušková, L. Dabrowská, K. Hejl,
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13401-4/2012
Internal Grant Agency of the Czech Ministry of Health - International
IN 75010330
Ministerstvo ZdravotnictvíCeskéRepubliky (CZ) - International
CZ.1.06/3.2.01/11.08435
European Regional Development Fund - International
NLK
ProQuest Central
from 2002-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2002-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2002-01-01 to 1 year ago
- MeSH
- Biomarkers urine MeSH
- Dipeptides metabolism urine MeSH
- Erythrocytes MeSH
- Ethylene Oxide toxicity MeSH
- Globins metabolism MeSH
- Hydrolysis MeSH
- Rats MeSH
- Leucine MeSH
- Environmental Monitoring MeSH
- Hazardous Substances toxicity MeSH
- Valine chemistry MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Ethylene oxide (EO), a genotoxic industrial chemical and sterilant, forms covalent adducts with DNA and also with nucleophilic amino acids in proteins. The adduct with N-terminal valine in globin [N-(2-hydroxyethyl)valine (HEV)] has been used in biomonitoring of cumulative exposures to EO. Here we studied in rats the fate of EO-adducted N-termini of globin after life termination of the erythrocytes. Rat erythrocytes were incubated with EO to produce the HEV levels in globin at 0.4-13.2 µmol/g as determined after acidic hydrolysis. Alternative hydrolysis of the isolated globin with enzyme pronase afforded N-(2-hydroxyethyl)-L-valyl-L-leucine (HEVL) and N-(2-hydroxyethyl)-L-valyl-L-histidine (HEVH), the EO-adducted N-terminal dipeptides of rat globin α- and β-chains, respectively. The ratio of HEVL/HEVH (1:3) reflected higher reactivity of EO with the β-chain. The EO-modified erythrocytes were then given intravenously to the recipient rats. HEVL and HEVH were found to be the ultimate cleavage products excreted in the rat urine. Finally, rats were dosed intraperitoneally with EO, 50 mg/kg. Herein, the initial level of globin-bound HEVL (11.7 ± 1.3 nmol/g) decreased almost linearly over 60 days corresponding to the life span of rat erythrocytes. Daily urinary excretion of HEVL was almost constant for 30-40 days, decreasing faster in the subsequent phase of elimination. Recoveries of the total urinary HEVL from its globin-bound form were 84 ± 6% and 101 ± 17% after administrations of EO and the EO-modified erythrocytes, respectively. In conclusion, urinary HEVL appears to be a promising novel non-invasive biomarker of human exposures to EO.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20022849
- 003
- CZ-PrNML
- 005
- 20201214124855.0
- 007
- ta
- 008
- 201125s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00204-019-02388-8 $2 doi
- 035 __
- $a (PubMed)30666356
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Mráz, Jaroslav $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic. jaroslav.mraz@szu.cz.
- 245 10
- $a N-(2-Hydroxyethyl)-L-valyl-L-leucine in rat urine as a hydrolytic cleavage product of ethylene oxide adduct with globin / $c J. Mráz, I. Hanzlíková, I. Linhart, Š. Dušková, L. Dabrowská, K. Hejl,
- 520 9_
- $a Ethylene oxide (EO), a genotoxic industrial chemical and sterilant, forms covalent adducts with DNA and also with nucleophilic amino acids in proteins. The adduct with N-terminal valine in globin [N-(2-hydroxyethyl)valine (HEV)] has been used in biomonitoring of cumulative exposures to EO. Here we studied in rats the fate of EO-adducted N-termini of globin after life termination of the erythrocytes. Rat erythrocytes were incubated with EO to produce the HEV levels in globin at 0.4-13.2 µmol/g as determined after acidic hydrolysis. Alternative hydrolysis of the isolated globin with enzyme pronase afforded N-(2-hydroxyethyl)-L-valyl-L-leucine (HEVL) and N-(2-hydroxyethyl)-L-valyl-L-histidine (HEVH), the EO-adducted N-terminal dipeptides of rat globin α- and β-chains, respectively. The ratio of HEVL/HEVH (1:3) reflected higher reactivity of EO with the β-chain. The EO-modified erythrocytes were then given intravenously to the recipient rats. HEVL and HEVH were found to be the ultimate cleavage products excreted in the rat urine. Finally, rats were dosed intraperitoneally with EO, 50 mg/kg. Herein, the initial level of globin-bound HEVL (11.7 ± 1.3 nmol/g) decreased almost linearly over 60 days corresponding to the life span of rat erythrocytes. Daily urinary excretion of HEVL was almost constant for 30-40 days, decreasing faster in the subsequent phase of elimination. Recoveries of the total urinary HEVL from its globin-bound form were 84 ± 6% and 101 ± 17% after administrations of EO and the EO-modified erythrocytes, respectively. In conclusion, urinary HEVL appears to be a promising novel non-invasive biomarker of human exposures to EO.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $x moč $7 D015415
- 650 _2
- $a dipeptidy $x metabolismus $x moč $7 D004151
- 650 _2
- $a monitorování životního prostředí $7 D004784
- 650 _2
- $a erytrocyty $7 D004912
- 650 _2
- $a ethylenoxid $x toxicita $7 D005027
- 650 _2
- $a globiny $x metabolismus $7 D005914
- 650 _2
- $a nebezpečné látky $x toxicita $7 D015386
- 650 _2
- $a hydrolýza $7 D006868
- 650 _2
- $a leucin $7 D007930
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a valin $x chemie $7 D014633
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hanzlíková, Iveta $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic.
- 700 1_
- $a Linhart, Igor $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 1905, 166 28, Prague, Czech Republic.
- 700 1_
- $a Dušková, Šárka $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic.
- 700 1_
- $a Dabrowská, Ludmila $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic.
- 700 1_
- $a Hejl, Kamil $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 1905, 166 28, Prague, Czech Republic.
- 773 0_
- $w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 93, č. 3 (2019), s. 603-613
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30666356 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214124855 $b ABA008
- 999 __
- $a ok $b bmc $g 1595168 $s 1113525
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 93 $c 3 $d 603-613 $e 20190121 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
- GRA __
- $a NT13401-4/2012 $p Internal Grant Agency of the Czech Ministry of Health $2 International
- GRA __
- $a IN 75010330 $p Ministerstvo ZdravotnictvíCeskéRepubliky (CZ) $2 International
- GRA __
- $a CZ.1.06/3.2.01/11.08435 $p European Regional Development Fund $2 International
- LZP __
- $a Pubmed-20201125